STOCK TITAN

IREN Financials

IREN NASDAQ
Trailing 12 months to September 30, 2026
Revenue $694.7M +0.9% YoY
Net Income -$1.4B -357.9% YoY
EPS (Diluted) -$4.08 -334.5% YoY
Free Cash Flow -$2.5B n/m YoY
Market Cap $6.5B as of Nov 18, 2026
Price / Sales 9.3x on $694.7M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 1.3x on $5.1B equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Sep 30, 2026 Reported Currency USD FYE June

Newest figures come from the 10-Q for Q1 FY2027, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IREN SEC filings page.

IREN Limited (IREN) reported $694.7M in revenue over the twelve months to Sep 30, 2026, up 0.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IREN FY2026

IREN’s reported cash generation remained positive, but asset expansion is heavily capital-funded and reinvestment overwhelms operating cash.

In FY2026, operating cash flow reached $2.1B while the company reported a net loss of $702.6M, showing accounting earnings and cash generation diverged sharply. Yet capital spending of $3.0B exceeded that cash inflow, leaving free cash flow at -$897.6M and making the investment program cash-consuming despite positive operating cash flow.

The latest balance-sheet expansion was accompanied by liabilities rising 933.5%, far faster than assets at 437.0%, indicating growth was not financed proportionally by equity. Debt-to-equity reached 1.8x while the current ratio was 3.6x, so reported short-term coverage coexists with a more leveraged capital structure.

Capital expenditures equaled 424.0% of revenue in FY2026, signaling an asset-heavy operating model in which expansion requires substantial reinvestment. Revenue still grew 41.1% from the prior year while free cash flow remained negative at -$897.6M, separating top-line growth from cash available after investment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 41 / 100
Financial Health Score 41/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of IREN Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
14

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. IREN Limited scores 14/100 on it among other operating companies.

Growth
98

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. IREN Limited scores 98/100 on it among other operating companies.

Leverage
18

IREN Limited carried $1.77 of long-term debt for every $1 of shareholders' equity at the end of fiscal year 2026, a debt-to-equity ratio of 1.77. With no positive EBITDA in fiscal year 2026, IREN Limited is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 18/100 among other operating companies measured the same way.

Liquidity
84

IREN Limited held $3.55 of current assets for every $1 of current liabilities at the end of fiscal year 2026, a current ratio of 3.55. Liquidity ranks operating companies on that ratio, and IREN Limited scores 84/100 among other operating companies.

Cash Flow
4

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. IREN Limited scores 4/100 on it among other operating companies.

Returns
25

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. IREN Limited scores 25/100 on it among other operating companies.

Altman Z-Score Distress
0.48

IREN Limited scores 0.48, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $1.0B against total assets of $15.8B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

IREN Limited passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.

Earnings Quality Mixed
N/A

IREN Limited reported a net loss of $702.6M while generating $2.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

IREN Limited reported an operating loss of $1.0B against $46.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$228.0M
YoY-5.0%
QoQ+66.2%

IREN Limited generated $228.0M in revenue in Q1 2027. This represents a decrease of 5.0% from the same quarter a year earlier. Against the prior quarter it is up 66.2%.

EBITDA
-$38.0M
YoY-522.2%
QoQn/m

IREN Limited's EBITDA was -$38.0M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 522.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$263.0M
YoY-168.3%
QoQn/m

IREN Limited reported a net loss of $263.0M in Q1 2027. This represents a decrease of 168.3% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.66
YoY-161.1%
QoQn/m

IREN Limited earned -$0.66 per diluted share (EPS) in Q1 2027. This represents a decrease of 161.1% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
-$1.6B
YoYn/m
QoQ-432.2%

IREN Limited recorded an outflow of $1.6B in free cash flow in Q1 2027, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 432.2%.

Cash & Debt
$3.5B
YoY+241.2%
QoQ-40.3%

IREN Limited held $3.5B in cash against $8.9B in long-term debt as of Q1 2027.

Dividends Per Share
$0.00
YoYn/m

IREN Limited paid $0.00 per share in dividends in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Shares Outstanding
Diluted avg 399M

IREN Limited had a weighted average of 399M diluted shares in Q1 2027; the shares outstanding count is not reported for that period.

Margins & Returns

Gross Margin
79.8%
YoY+13.6pp
QoQ+4.1pp

IREN Limited's gross margin was 79.8% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.

Operating Margin
-81.6%
YoY-49.9pp

IREN Limited's operating margin was -81.6% in Q1 2027, reflecting core business profitability. This is down 49.9 percentage points from the same quarter a year earlier.

Return on Equity
-5.1%
YoY-18.5pp
QoQ+11.2pp

IREN Limited's quarterly ROE was -5.1% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is down 18.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.2 percentage points.

Net Margin

Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$7.0M
YoYn/m

IREN Limited invested $7.0M in research and development in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Capital Expenditures
$2.1B
YoY+1083.9%
QoQ+60.4%

IREN Limited invested $2.1B in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 1083.9% from the same quarter a year earlier. Against the prior quarter it is up 60.4%.

Share Buybacks

Not reported for Q1 2027.

IREN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IREN quarterly income statement
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Revenue$228.0M-5.0%$137.2M-26.7%$144.8M0.0%$184.7M+59.0%$240.0M+354.9%$187.3M$144.8M$116.1M
Cost of Revenue$46.0M-43.2%$33.3M-37.0%$39.9M-4.8%$65.8M+103.6%$81.0M+154.2%$52.9M$42.0M$32.3M
Gross Profit$182.0M+14.5%$103.9M-22.7%$104.9M+1.9%$118.9M+41.8%$159.0M+660.6%$134.4M$102.9M$83.8M
R&D Expenses$7.0Mn/mN/AN/AN/A$0N/AN/AN/A
SG&A Expenses$217.0M+57.2%$128.3M+140.6%$81.8M+181.0%$100.8M+248.7%$138.0M+448.2%$53.3M$29.1M$28.9M
Operating Income-$186.0Mn/m-$620.4M-3568.2%-$233.5M-899.3%-$116.4M-772.5%-$76.0Mn/m$17.9M$29.2M$17.3M
EBITDA-$38.0M-522.2%-$508.3M-722.1%-$112.3M-246.7%-$17.2M-132.3%$9.0Mn/m$81.7M$76.5M$53.4M
Interest Expense$56.0M+460.0%$11.8M+156.8%$14.8M+260.2%$10.7M+519.5%$10.0M+45354.5%$4.6M$4.1M$1.7M
Income Tax$2.0M-99.0%-$8.0Mn/m-$6.3M-224.2%-$182.5M-6173.9%$191.0M+14798.6%-$2.8M$5.0M$3.0M
Net Income-$263.0M-168.3%-$684.0M-487.1%-$247.8Mn/m-$155.4Mn/m$385.0Mn/m$176.7M-$16.1M-$21.9M
EPS (Basic)-$0.66-146.5%-$2.16-354.1%-$0.74n/m-$0.52n/m$1.42$0.85-$0.07-$0.10
EPS (Diluted)-$0.66-161.1%-$2.16-360.2%-$0.74n/m-$0.52n/m$1.08$0.83-$0.07-$0.10
Diluted Shares (Avg)399M+10.2%N/A334M+52.6%298M+41.6%362MN/A219M210M

IREN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IREN quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Total Assets$20.6B+383.0%$15.8B+437.0%$7.3B$7.0B$4.3B$2.9B+155.1%N/AN/A
Current Assets$6.3B+460.4%$7.9B+1129.9%$2.4B$3.4B$1.1B$641.2M+41.7%N/AN/A
Cash & Equivalents$3.5B+241.2%$5.9B+944.4%$2.2B+1100.7%$3.3B+663.1%$1.0B+947.0%$564.5M+39.5%$184.3M$427.3M
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0-100.0%$0$0
Accounts Receivable$192.0M+695.4%$21.0M+1242.7%$69.1M$9.6M$24.1M$1.6M+928.9%N/AN/A
Long-Term Investments$0-100.0%$0-100.0%$0n/m$0n/m$681.4Mn/m$211.6Mn/m$0$0
Goodwill$450.0M$36.0Mn/m$1.2MN/AN/A$0n/mN/AN/A
Total Liabilities$15.5B+1013.9%$11.6B+933.5%$4.6B$4.5B$1.4B$1.1B+1928.8%N/AN/A
Current Liabilities$3.9B+1836.7%$2.2B+1387.1%$651.4M$682.1M$203.7M$149.3M+192.4%N/AN/A
Non-Current Liabilities$11.6B+872.7%$9.4B+863.9%$3.9B$3.8B$1.2B$973.5M+22677.0%N/AN/A
Long-Term Debt$8.9B+827.9%$7.4B+671.1%$3.7B$3.7B$964.2M$962.8Mn/mN/AN/A
Total Equity$5.1B+77.9%$4.2B+130.4%$2.7B+98.2%$2.5B+101.6%$2.9B+154.6%$1.8B+65.6%$1.3B$1.2B
Retained Earnings-$1.6Bn/m-$1.3Bn/m-$614.8M-$367.0M-$211.6M-$596.2Mn/mN/AN/A

Not reported in any period shown, so not listed: Inventory.

IREN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IREN quarterly cash flow statement
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Operating Cash Flow$529.0M+272.5%$1.8B+1655.9%$75.3M-19.1%$72.0M+34.4%$142.0Mn/m$103.1M$93.1M$53.6M
Depreciation & Amortization$148.0M+74.1%$112.1M+75.6%$121.2M+156.3%$99.2M+174.9%$85.0M+150.5%$63.8M$47.3M$36.1M
Stock-Based Compensation$106.0M+47.2%N/A$31.5M+305.2%$58.2M+630.2%$72.0M+779.8%N/A$7.8M$8.0M
Capital Expenditures$2.1B+1083.9%$1.3B+621.8%$949.2M+557.1%$540.0M+288.3%$180.0M+70.1%$184.1M$144.5M$139.1M
Free Cash Flow-$1.6Bn/m$482.2Mn/m-$873.8Mn/m-$468.0Mn/m-$38.0Mn/m-$81.0M-$51.3M-$85.5M
Investing Cash Flow-$5.1Bn/m-$2.1Bn/m-$1.5Bn/m-$851.8Mn/m-$280.0Mn/m-$370.2M-$442.9M-$180.3M
Financing Cash Flow$2.8B+358.6%$5.7B+784.2%$355.0M+231.4%$3.0B+558.1%$606.0M+615.7%$645.9M$107.1M$457.0M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

IREN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IREN quarterly financial ratios
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Gross Margin79.8%+13.6pp75.7%+3.9pp72.4%+1.4pp64.4%-7.8pp66.3%+26.6pp71.8%71.0%72.2%
Operating Margin-81.6%-49.9pp-452.1%-161.3%-63.0%-77.9pp-31.7%+57.6pp9.6%20.2%14.9%
Net Margin-115.3%-498.4%-171.2%-84.1%-65.3pp160.4%94.3%-11.2%-18.9%
Return on Equity-5.1%-18.5pp-16.3%-26.1pp-9.3%-8.1pp-6.2%-4.4pp13.4%+18.0pp9.7%-1.2%-1.8%
Return on Assets-1.3%-10.3pp-4.3%-10.3pp-3.4%-2.2%9.0%6.0%N/AN/A
Current Ratio1.60-3.9x3.55-0.7x3.724.965.524.29-4.6xN/AN/A
Debt-to-Equity1.75+1.4x1.77+1.2x1.381.470.340.53+0.5xN/AN/A
Liabilities-to-Equity3.03+2.5x2.77+2.2x1.731.800.480.62+0.6xN/AN/A
Asset Turnover0.010.0x0.01-0.1x0.020.030.060.06N/AN/A
FCF Margin-702.6%351.4%-603.5%-253.4%-15.8%-43.2%-35.5%-73.6%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
IREN Limited IREN FY2026 $707.0M -$702.6M -99.4% $6.5B 41/100
Hut 8 Corp. HUT FY2025 $235.1M -$226.1M -96.2% $6.9B 51/100
XP Inc. XP FY2025 $3.4B $943.9M 28.1% $7.0B 56/100
Riot Platforms, Inc. RIOT FY2025 $647.4M -$663.2M N/A $6.8B 37/100
TeraWulf Inc. WULF FY2025 $168.5M -$661.4M N/A $6.0B 67/100
StoneX Group Inc. SNEX FY2025 $131.0B $305.9M 0.2% $6.5B 63/100

Frequently Asked Questions

IREN Limited (IREN) reported $707.0M in total revenue for fiscal year 2026. This represents a 41.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

IREN Limited (IREN) revenue grew by 41.1% year-over-year, from $501.0M to $707.0M in fiscal year 2026.

No, IREN Limited (IREN) reported a net loss of $1.4B over the trailing 12 months to September 30, 2026. In fiscal year 2026 it reported a net loss of $702.6M, with a net profit margin of -99.4%.

IREN Limited (IREN) reported diluted earnings per share of -$2.22 for fiscal year 2026. This represents a -669.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

IREN Limited (IREN) had EBITDA of -$629.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, IREN Limited (IREN) had $5.9B in cash and equivalents against $7.4B in long-term debt.

IREN Limited (IREN) had a gross margin of 68.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

IREN Limited (IREN) had a net profit margin of -99.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

IREN Limited (IREN) has a return on equity of -16.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

IREN Limited (IREN) recorded an outflow of $897.6M in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

IREN Limited (IREN) generated $2.1B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

IREN Limited (IREN) had $15.8B in total assets as of fiscal year 2026, including both current and long-term assets.

IREN Limited (IREN) invested $3.0B in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

IREN Limited (IREN) had a current ratio of 3.55 as of fiscal year 2026, which is generally considered healthy.

IREN Limited (IREN) had a debt-to-equity ratio of 1.77 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

IREN Limited (IREN) had a liabilities-to-equity ratio of 2.77 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

IREN Limited (IREN) had a return on assets of -4.5% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

IREN Limited (IREN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $6.5B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

IREN Limited (IREN) trades at 9.3x sales, its market capitalization divided by $694.7M revenue, trailing 12 months to September 30, 2026. The market capitalization is $6.5B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

IREN Limited (IREN) has an Altman Z-Score of 0.48, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

IREN Limited (IREN) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

IREN Limited (IREN) reported a net loss of $702.6M while generating $2.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

IREN Limited (IREN) reported an operating loss of $1.0B against $46.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

IREN Limited (IREN) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top